HOUSE-BILL 8143: H.R.8143 - Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

HOUSE-BILL 8143 aims to enhance access to affordable medications for seniors by mandating that Medicare Part D prescription drug plans include specific generic drugs and biosimilar products on their formularies. The legislation addresses major themes of health care access and economic rights, particularly focusing on the affordability of medications for Medicare beneficiaries. Key provisions include the requirement for PDP sponsors to include these drugs in a preferred position, thereby reducing out-of-pocket costs and prohibiting restrictive access measures that could limit availability compared to reference drugs. The bill also provides clear definitions to ensure enforceability of its requirements. Implementation is expected to occur within a defined timeline, although specific dates are not outlined in the analysis. The potential impacts include improved financial security and health outcomes for seniors, while also raising constitutional concerns regarding federal authority over the pharmaceutical market and the rights of private insurance plans to manage their formularies.

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.